<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>80(Pt 11)</volume><submitter>Blockhaus T</submitter><pubmed_abstract>Starting from (p-tolylsulfinyl)ferrocene (1), a mixture of the complete series [CpFe{C&lt;sub>5&lt;/sub>H&lt;sub>5-n&lt;/sub>(SOTol-p)&lt;sub>n&lt;/sub>}] (n = 2-4) (2-4) in all regioisomers was obtained. After chromatographic separation, crystals of 1,2-bis[(4-methylbenzene)sulfinyl]ferrocene, 2a, and 1,3-bis[(4-methylbenzene)sulfinyl]ferrocene, 2b, both [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>19&lt;/sub>H&lt;sub>17&lt;/sub>O&lt;sub>2&lt;/sub>S&lt;sub>2&lt;/sub>)], as well as of 1,2,3-tris[(4-methylbenzene)sulfinyl]ferrocene, [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>26&lt;/sub>H&lt;sub>23&lt;/sub>O&lt;sub>3&lt;/sub>S&lt;sub>3&lt;/sub>)], 3a, and 1,2,3,4-tetrakis[(4-methylbenzene)sulfinyl]ferrocene ethyl acetate 0.75-solvate, [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>33&lt;/sub>H&lt;sub>29&lt;/sub>O&lt;sub>4&lt;/sub>S&lt;sub>4&lt;/sub>)]·0.75C&lt;sub>4&lt;/sub>H&lt;sub>8&lt;/sub>O&lt;sub>2&lt;/s</pubmed_abstract><journal>Acta crystallographica. Section C, Structural chemistry</journal><pagination>716-727</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11535883</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular and crystal structures of six poly(arylsulfinyl)- and poly(arylsulfanyl)ferrocenes.</pubmed_title><pmcid>PMC11535883</pmcid><pubmed_authors>Sunkel K</pubmed_authors><pubmed_authors>Blockhaus T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular and crystal structures of six poly(arylsulfinyl)- and poly(arylsulfanyl)ferrocenes.</name><description>Starting from (p-tolylsulfinyl)ferrocene (1), a mixture of the complete series [CpFe{C&lt;sub>5&lt;/sub>H&lt;sub>5-n&lt;/sub>(SOTol-p)&lt;sub>n&lt;/sub>}] (n = 2-4) (2-4) in all regioisomers was obtained. After chromatographic separation, crystals of 1,2-bis[(4-methylbenzene)sulfinyl]ferrocene, 2a, and 1,3-bis[(4-methylbenzene)sulfinyl]ferrocene, 2b, both [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>19&lt;/sub>H&lt;sub>17&lt;/sub>O&lt;sub>2&lt;/sub>S&lt;sub>2&lt;/sub>)], as well as of 1,2,3-tris[(4-methylbenzene)sulfinyl]ferrocene, [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>26&lt;/sub>H&lt;sub>23&lt;/sub>O&lt;sub>3&lt;/sub>S&lt;sub>3&lt;/sub>)], 3a, and 1,2,3,4-tetrakis[(4-methylbenzene)sulfinyl]ferrocene ethyl acetate 0.75-solvate, [Fe(C&lt;sub>5&lt;/sub>H&lt;sub>5&lt;/sub>)(C&lt;sub>33&lt;/sub>H&lt;sub>29&lt;/sub>O&lt;sub>4&lt;/sub>S&lt;sub>4&lt;/sub>)]·0.75C&lt;sub>4&lt;/sub>H&lt;sub>8&lt;/sub>O&lt;sub>2&lt;/s</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T13:17:53.452Z</modification><creation>2025-04-20T03:55:07.825Z</creation></dates><accession>S-EPMC11535883</accession><cross_references><pubmed>39365563</pubmed><doi>10.1107/S2053229624009318</doi></cross_references></HashMap>